chr11-102625267-T-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004771.4(MMP20):āc.53A>Cā(p.Lys18Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.655 in 1,613,374 control chromosomes in the GnomAD database, including 347,848 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_004771.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MMP20 | NM_004771.4 | c.53A>C | p.Lys18Thr | missense_variant | 1/10 | ENST00000260228.3 | NP_004762.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MMP20 | ENST00000260228.3 | c.53A>C | p.Lys18Thr | missense_variant | 1/10 | 1 | NM_004771.4 | ENSP00000260228 | P1 | |
MMP20-AS1 | ENST00000542119.1 | n.87-1392T>G | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.649 AC: 98565AN: 151816Hom.: 32142 Cov.: 30
GnomAD3 exomes AF: 0.665 AC: 167017AN: 251102Hom.: 55914 AF XY: 0.667 AC XY: 90468AN XY: 135716
GnomAD4 exome AF: 0.656 AC: 958554AN: 1461438Hom.: 315667 Cov.: 48 AF XY: 0.656 AC XY: 477161AN XY: 727022
GnomAD4 genome AF: 0.649 AC: 98662AN: 151936Hom.: 32181 Cov.: 30 AF XY: 0.653 AC XY: 48460AN XY: 74250
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Amelogenesis imperfecta hypomaturation type 2A2 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at